Marketing-authorisation holder ยท Spain
Laboratoire Glaxosmithkline
8 medicines in 1 country, as authorisation holder.
Loading your pageโฆ
Marketing-authorisation holder ยท Spain
8 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| FLIXONASE 50 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL50 ยตg/dosis ยท Suspensiรณn para pulverizaciรณn nasal | Fluticasone | Spain | Marketed | 2026 |
| HAVRIX 1440 ADULTO, SUSPENSION INYECTABLE EN JERINGA PRECARGADA1440 u elisa ยท Suspensiรณn inyectable en jeringa precargada | Antigeno hepatitis a | Spain | Marketed | 2026 |
| LAMICTAL 200 MG COMPRIMIDOS MASTICABLES/DISPERSABLES200 mg ยท Comprimido masticable y dispersable | Lamotrigine | Spain | Authorised | 2026 |
| LAMICTAL 200 mg COMPRIMIDOS MASTICABLES/DISPERSABLES200 mg ยท Comprimido masticable y dispersable | Lamotrigine | Spain | Marketed | 2024 |
| LAMICTAL 200 MG COMPRIMIDOS MASTICABLES/DISPERSABLES200 mg ยท Comprimido masticable y dispersable | Lamotrigine | Spain | Marketed | 2024 |
| LAMICTAL 200 mg COMPRIMIDOS MASTICABLES/DISPERSABLES200 mg ยท Comprimido masticable y dispersable | Lamotrigine | Spain | Marketed | 2024 |
| SEBIPROX 15 MG/G CHAMPU1,5 g ยท Champรบ | Ciclopirox | Spain | Withdrawn | 2020 |
| SEBIPROX 15 MG/G CHAMPU1,5 g ยท Champรบ | Ciclopirox | Spain | Withdrawn | 2023 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 8 | 6 | 2 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.